{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:02:58Z","timestamp":1779847378922,"version":"3.53.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":146,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Natural Provincial Science Foundation of China","award":["2020J011017"],"award-info":[{"award-number":["2020J011017"]}]},{"name":"Fujian Natural Provincial Science Foundation of China","award":["2023J1660"],"award-info":[{"award-number":["2023J1660"]}]},{"name":"Joint Funds for Science and Technology Innovation of Fujian Province","award":["2019Y9058"],"award-info":[{"award-number":["2019Y9058"]}]},{"name":"Joint Funds for Science and Technology Innovation of Fujian Province","award":["2020Y9084"],"award-info":[{"award-number":["2020Y9084"]}]},{"name":"National Key Clinical Specialty Construction Project of Neurology","award":["0802714"],"award-info":[{"award-number":["0802714"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05929-2","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:19:42Z","timestamp":1779844782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apolipoprotein E Deficiency Attenuates Neuroinflammatory Responses and Demyelination in Experimental Autoimmune Encephalomyelitis"],"prefix":"10.1007","volume":"63","author":[{"given":"Xiaohui","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"5929_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22(1):78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7","journal-title":"Lancet Neurol"},{"issue":"3","key":"5929_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"GBD 2016 Multiple Sclerosis Collaborators","year":"2019","unstructured":"GBD 2016 Multiple Sclerosis Collaborators (2019) Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(3):269\u2013285. https:\/\/doi.org\/10.1016\/S1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"5929_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15(9):545\u2013558. https:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5929_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.25197","volume":"83","author":"R Magliozzi","year":"2018","unstructured":"Magliozzi R, Howell OW, Nicholas R et al (2018) Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann Neurol 83(4):739\u2013755. https:\/\/doi.org\/10.1002\/ana.25197","journal-title":"Ann Neurol"},{"issue":"7","key":"5929_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/WNL.0000000000000125","volume":"82","author":"PS Sorensen","year":"2014","unstructured":"Sorensen PS, Lisby S, Grove R et al (2014) Safety and efficacy of Ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study. Neurology 82(7):573\u2013581. https:\/\/doi.org\/10.1212\/WNL.0000000000000125","journal-title":"Neurology"},{"issue":"12","key":"5929_CR6","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Cree BAC (2020) Treatment of multiple sclerosis: a review. Am J Med 133(12):1380-1390.e2. https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.049","journal-title":"Am J Med"},{"key":"5929_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104011","volume":"65","author":"A Naseri","year":"2022","unstructured":"Naseri A, Baghernezhad K, Seyedi-Sahebari S et al (2022) The association of apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis. Mult Scler Relat Disord 65:104011. https:\/\/doi.org\/10.1016\/j.msard.2022.104011","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"5929_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S1474-4422(14)70041-9","volume":"13","author":"S Sawcer","year":"2014","unstructured":"Sawcer S, Franklin RJ, Ban M (2014) Multiple sclerosis genetics. Lancet Neurol 13(7):700\u2013709. https:\/\/doi.org\/10.1016\/S1474-4422(14)70041-9","journal-title":"Lancet Neurol"},{"issue":"6","key":"5929_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin Y, Li F, Sonoustoun B et al (2022) APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol 143(6):641\u2013662. https:\/\/doi.org\/10.1007\/s00401-022-02421-8","journal-title":"Acta Neuropathol"},{"key":"5929_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102389","volume":"45","author":"M McComb","year":"2020","unstructured":"McComb M, Parambi R, Browne RW et al (2020) Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis. Mult Scler Relat Disord 45:102389. https:\/\/doi.org\/10.1016\/j.msard.2020.102389","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"5929_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/339269","volume":"70","author":"S Schmidt","year":"2002","unstructured":"Schmidt S, Barcellos LF, DeSombre K et al (2002) Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet 70(3):708\u2013717. https:\/\/doi.org\/10.1086\/339269","journal-title":"Am J Hum Genet"},{"issue":"6","key":"5929_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1468-1331.2006.01360.x","volume":"13","author":"M Pinholt","year":"2006","unstructured":"Pinholt M, Frederiksen JL, Christiansen M (2006) The association between apolipoprotein E and multiple sclerosis. Eur J Neurol 13(6):573\u2013580. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01360.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"5929_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/wnl.57.5.853","volume":"57","author":"F Fazekas","year":"2001","unstructured":"Fazekas F, Strasser-Fuchs S, Kollegger H et al (2001) Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57(5):853\u2013857. https:\/\/doi.org\/10.1212\/wnl.57.5.853","journal-title":"Neurology"},{"issue":"1","key":"5929_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gene.2012.09.010","volume":"511","author":"YW Yin","year":"2012","unstructured":"Yin YW, Zhang YD, Wang JZ et al (2012) Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects. Gene 511(1):12\u201317. https:\/\/doi.org\/10.1016\/j.gene.2012.09.010","journal-title":"Gene"},{"issue":"2","key":"5929_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25(2):112\u2013123. https:\/\/doi.org\/10.1016\/j.molmed.2018.11.005","journal-title":"Trends Mol Med"},{"issue":"6","key":"5929_CR16","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/brain\/awaa117","volume":"143","author":"NL Fransen","year":"2020","unstructured":"Fransen NL, Hsiao CC, van der Poel M et al (2020) Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain 143(6):1714\u20131730. https:\/\/doi.org\/10.1093\/brain\/awaa117","journal-title":"Brain"},{"issue":"7772","key":"5929_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer L, Velmeshev D, Holmqvist S et al (2019) Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573(7772):75\u201382. https:\/\/doi.org\/10.1038\/s41586-019-1404-z","journal-title":"Nature"},{"issue":"6","key":"5929_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrneurol.2016.59","volume":"12","author":"M Absinta","year":"2016","unstructured":"Absinta M, Sati P, Reich DS (2016) Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol 12(6):358\u2013368. https:\/\/doi.org\/10.1038\/nrneurol.2016.59","journal-title":"Nat Rev Neurol"},{"issue":"7796","key":"5929_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","volume":"578","author":"MA Wheeler","year":"2020","unstructured":"Wheeler MA, Clark IC, Tjon EC et al (2020) MAFG-driven astrocytes promote CNS inflammation. Nature 578(7796):593\u2013599. https:\/\/doi.org\/10.1038\/s41586-020-1999-0","journal-title":"Nature"},{"issue":"7878","key":"5929_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta M, Maric D, Gharagozloo M et al (2021) A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 597(7878):709\u2013714. https:\/\/doi.org\/10.1038\/s41586-021-03892-7","journal-title":"Nature"},{"key":"5929_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101594","volume":"59","author":"S Parhizkar","year":"2022","unstructured":"Parhizkar S, Holtzman DM (2022) APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Semin Immunol 59:101594. https:\/\/doi.org\/10.1016\/j.smim.2022.101594","journal-title":"Semin Immunol"},{"issue":"10","key":"5929_CR22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M et al (2021) Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109(10):1657-1674.e7. https:\/\/doi.org\/10.1016\/j.neuron.2021.03.024","journal-title":"Neuron"},{"key":"5929_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/186813","volume":"2010","author":"HL Zhang","year":"2010","unstructured":"Zhang HL, Wu J, Zhu J (2010) The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol 2010:186813. https:\/\/doi.org\/10.1155\/2010\/186813","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"5929_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang N, Wang M, Jeevaratnam S et al (2022) Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol Neurodegener 17(1):75. https:\/\/doi.org\/10.1186\/s13024-022-00577-1","journal-title":"Mol Neurodegener"},{"issue":"1\u20132","key":"5929_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2014.03.010","volume":"271","author":"S Shin","year":"2014","unstructured":"Shin S, Walz KA, Archambault AS et al (2014) Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. J Neuroimmunol 271(1\u20132):8\u201317. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.03.010","journal-title":"J Neuroimmunol"},{"issue":"11","key":"5929_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028977","volume":"8","author":"S Glatigny","year":"2018","unstructured":"Glatigny S, Bettelli E (2018) Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harb Perspect Med 8(11):a028977. https:\/\/doi.org\/10.1101\/cshperspect.a028977","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5929_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-7862-5_17","volume":"1791","author":"M Giralt","year":"2018","unstructured":"Giralt M, Molinero A, Hidalgo J (2018) Active induction of experimental autoimmune encephalomyelitis (EAE) with MOG35-55 in the mouse. Methods Mol Biol 1791:227\u2013232. https:\/\/doi.org\/10.1007\/978-1-4939-7862-5_17","journal-title":"Methods Mol Biol"},{"issue":"4","key":"5929_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"19","key":"5929_CR29","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","volume":"112","author":"T Garton","year":"2024","unstructured":"Garton T, Gadani SP, Gill AJ et al (2024) Neurodegeneration and demyelination in multiple sclerosis. Neuron 112(19):3231\u20133251. https:\/\/doi.org\/10.1016\/j.neuron.2024.05.025","journal-title":"Neuron"},{"issue":"23","key":"5929_CR30","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddab184","volume":"30","author":"D Kim","year":"2021","unstructured":"Kim D, An H, Fan C et al (2021) Identifying oligodendrocyte enhancers governing Plp1 expression. Hum Mol Genet 30(23):2225\u20132239. https:\/\/doi.org\/10.1093\/hmg\/ddab184","journal-title":"Hum Mol Genet"},{"issue":"1\u20132","key":"5929_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nbd.2004.12.006","volume":"19","author":"JC Murtie","year":"2005","unstructured":"Murtie JC, Zhou YX, Le TQ et al (2005) PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19(1\u20132):171\u2013182. https:\/\/doi.org\/10.1016\/j.nbd.2004.12.006","journal-title":"Neurobiol Dis"},{"issue":"7","key":"5929_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/dneu.22849","volume":"81","author":"E Sock","year":"2021","unstructured":"Sock E, Wegner M (2021) Using the lineage determinants Olig2 and Sox10 to explore transcriptional regulation of oligodendrocyte development. Dev Neurobiol 81(7):892\u2013901. https:\/\/doi.org\/10.1002\/dneu.22849","journal-title":"Dev Neurobiol"},{"issue":"1","key":"5929_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2001.tb00383.x","volume":"11","author":"AT Campagnoni","year":"2001","unstructured":"Campagnoni AT, Skoff RP (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11(1):74\u201391. https:\/\/doi.org\/10.1111\/j.1750-3639.2001.tb00383.x","journal-title":"Brain Pathol"},{"issue":"8","key":"5929_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001624","volume":"11","author":"Z Li","year":"2013","unstructured":"Li Z, Park Y, Marcotte EM (2013) A bacteriophage tailspike domain promotes self-cleavage of a human membrane-bound transcription factor, the myelin regulatory factor MYRF. PLoS Biol 11(8):e1001624. https:\/\/doi.org\/10.1371\/journal.pbio.1001624","journal-title":"PLoS Biol"},{"issue":"2","key":"5929_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/glia.23242","volume":"66","author":"T Turnescu","year":"2018","unstructured":"Turnescu T, Arter J, Reiprich S et al (2018) Sox8 and Sox10 jointly maintain myelin gene expression in oligodendrocytes. Glia 66(2):279\u2013294. https:\/\/doi.org\/10.1002\/glia.23242","journal-title":"Glia"},{"issue":"Pt 7","key":"5929_CR36","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1242\/jcs.140855","volume":"127","author":"J Torvund-Jensen","year":"2014","unstructured":"Torvund-Jensen J, Steengaard J, Reimer L et al (2014) Transport and translation of MBP mRNA is regulated differently by distinct hnRNP proteins. J Cell Sci 127(Pt 7):1550\u20131564. https:\/\/doi.org\/10.1242\/jcs.140855","journal-title":"J Cell Sci"},{"issue":"1","key":"5929_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02041-7","volume":"18","author":"H Wu","year":"2021","unstructured":"Wu H, Zheng J, Xu S et al (2021) Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation 18(1):2. https:\/\/doi.org\/10.1186\/s12974-020-02041-7","journal-title":"J Neuroinflammation"},{"issue":"10","key":"5929_CR38","doi-asserted-by":"publisher","first-page":"11363","DOI":"10.1021\/acsami.9b23004","volume":"12","author":"T Ganbold","year":"2020","unstructured":"Ganbold T, Bao Q, Zandan J et al (2020) Modulation of microglia polarization through silencing of NF-\u03baB p65 by functionalized curdlan nanoparticle-mediated RNAi. ACS Appl Mater Interfaces 12(10):11363\u201311374. https:\/\/doi.org\/10.1021\/acsami.9b23004","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"5929_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"A Bar-Or","year":"2021","unstructured":"Bar-Or A, Li R (2021) Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol 20(6):470\u2013483. https:\/\/doi.org\/10.1016\/S1474-4422(21)00063-6","journal-title":"Lancet Neurol"},{"key":"5929_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https:\/\/doi.org\/10.1186\/1742-2094-11-98","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5929_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R et al (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47(3):566-581.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"issue":"6","key":"5929_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5582\/bst.2025.01148","volume":"19","author":"J Chen","year":"2026","unstructured":"Chen J, Zhao S, Zhou Y et al (2026) APOE4 reprograms microglial lipid metabolism in Alzheimer\u2019s disease: mechanisms and therapeutic implications. Biosci Trends 19(6):641\u2013658. https:\/\/doi.org\/10.5582\/bst.2025.01148","journal-title":"Biosci Trends"},{"issue":"43","key":"5929_CR43","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, Liu CC, Painter MM et al (2015) Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J Biol Chem 290(43):26043\u201326050. https:\/\/doi.org\/10.1074\/jbc.M115.679043","journal-title":"J Biol Chem"},{"issue":"6238","key":"5929_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/341162a0","volume":"341","author":"U Beisiegel","year":"1989","unstructured":"Beisiegel U, Weber W, Ihrke G et al (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341(6238):162\u2013164. https:\/\/doi.org\/10.1038\/341162a0","journal-title":"Nature"},{"key":"5929_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101121","volume":"21","author":"J Peng","year":"2019","unstructured":"Peng J, Pang J, Huang L et al (2019) LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1\/PI3K\/Akt pathway after subarachnoid hemorrhage in rats. Redox Biol 21:101121. https:\/\/doi.org\/10.1016\/j.redox.2019.101121","journal-title":"Redox Biol"},{"issue":"7","key":"5929_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115961","volume":"44","author":"RA Stephenson","year":"2025","unstructured":"Stephenson RA, Sepulveda J, Johnson KR et al (2025) Triglyceride metabolism controls inflammation and microglial phenotypes associated with APOE4. Cell Rep 44(7):115961. https:\/\/doi.org\/10.1016\/j.celrep.2025.115961","journal-title":"Cell Rep"},{"issue":"1","key":"5929_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","volume":"18","author":"HYF Yong","year":"2022","unstructured":"Yong HYF, Yong VW (2022) Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis. Nat Rev Neurol 18(1):40\u201355. https:\/\/doi.org\/10.1038\/s41582-021-00581-x","journal-title":"Nat Rev Neurol"},{"issue":"Pt11","key":"5929_CR48","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt11):2705\u20132712. https:\/\/doi.org\/10.1093\/brain\/awh641","journal-title":"Brain"},{"issue":"4","key":"5929_CR49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","volume":"125","author":"S Singh","year":"2013","unstructured":"Singh S, Metz I, Amor S et al (2013) Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol 125(4):595\u2013608. https:\/\/doi.org\/10.1007\/s00401-013-1082-0","journal-title":"Acta Neuropathol"},{"issue":"9","key":"5929_CR50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00415-003-0163-8","volume":"250","author":"G Savettieri","year":"2003","unstructured":"Savettieri G, Andreoli V, Bonavita S et al (2003) Apolipoprotein E genotype does not influence the progression of multiple sclerosis. J Neurol 250(9):1094\u20131098. https:\/\/doi.org\/10.1007\/s00415-003-0163-8","journal-title":"J Neurol"},{"issue":"2","key":"5929_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1191\/1352458504ms998oa","volume":"10","author":"M Santos","year":"2003","unstructured":"Santos M, Costa MC, Edite Rio M et al (2003) Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin. Mult Scler 10(2):153\u2013157. https:\/\/doi.org\/10.1191\/1352458504ms998oa","journal-title":"Mult Scler"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05929-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:19:43Z","timestamp":1779844783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5929"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05929-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of Fujian Medical University and were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"654"}}